| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $130.5M | -1.0% |
| Cost of Revenue | $95.3M | -1.2% |
| Gross Profit | $35.3M | -0.5% |
| R&D Expense | $1.4M | -16.6% |
| SG&A Expense | $11.1M | +8.9% |
| Operating Income | -$2.4M | -14.4% |
| Pre-tax Income | -$4.3M | -90.1% |
| Income Tax | $2.8M | +608.6% |
| Net Income | -$6.1M | -411.2% |
| EPS (Basic) | -$3.20 | -2361.5% |
| EPS (Diluted) | -$3.20 | -2361.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.9M | -58.7% |
| Accounts Receivable | $13.8M | -31.8% |
| Inventory | $15.3M | +9.6% |
| Current Assets | $51.5M | -2.6% |
| Total Assets | $69.5M | -7.9% |
| Current Liabilities | $43.9M | +3.2% |
| Total Liabilities | $53.9M | +0.1% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $673K | +109.1% |
| Capital Expenditures | $886K | -59.8% |
| Investing Cash Flow | -$1.0M | +64.7% |
| Financing Cash Flow | -$2.6M | -134.9% |
| Free Cash Flow | -$213K | +97.8% |
| $17.3M |
| -22.3% |